Sussex Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
    • Sussex-wide protocols
    • Brighton & Hove protocols
    • East Sussex protocols
    • West Sussex protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
    • 2021
    • 2022
    • 2023
    • 2024
    • 2025
    • 2026
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
      • 7.1 Bladder and urinary disorders
      • 7.2 Bladder instillations and urological surgery
      • 7.3 Contraception
      • 7.4 Erectile and ejaculatory conditions
      • 7.5 Gynaecological conditions
      • 7.6 Obstetrics
        • 7.6.1 Induction of labour
        • 7.6.2 Postpartum haemorrhage
        • 7.6.3 Premature labour
        • 7.6.4 Termination of pregnancy
      • 7.7 Vaginal and vulval conditions
      • 7.8 Other Genito-urinary system items
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Dinoprostone

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Prostin E2 vaginal gel and tablet are not bioequivalent.

Dinoprostone 1mg/2.5ml vaginal gel

Pack
3 ml

Dinoprostone 2mg/2.5ml vaginal gel

Pack
3 ml

Dinoprostone 3mg pessaries

Pack
8 pessary

Dinoprostone 10mg vaginal device

Pack
1 device
5 device

Dinoprostone 750micrograms/0.75ml solution for infusion ampoules

Pack
1 ampoule

Dinoprostone 5mg/0.5ml solution for infusion ampoules

Pack
1 ampoule

Dinoprostone 5mg/0.5ml extraamniotic solution ampoules

Pack
1 ampoule

Propess 10mg vaginal delivery system

Pack
5 device

Prostin E2 3mg vaginal tablets

Pack
8 pessary

Oxytocin

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Induction and augmentation of labour. Refer to SmPC.

Oxytocin 10units/1ml solution for injection ampoules

Pack
5 ampoule
10 ampoule

Oxytocin 10units/1ml concentrate for solution for infusion ampoules

Pack
10 ampoule (2 x 5 ampoules)

Syntocinon 10units/1ml solution for injection ampoules

Pack
5 ampoule

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026